This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Raloxifene Hydrochloride

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Raloxifene Hydrochloride Means in Everyday Medical Language

Raloxifene hydrochloride is a medicine often called Evista. It belongs to a group of drugs known as selective estrogen receptor modulators, or SERMs. This means it can block or mimic the hormone estrogen’s effects depending on the part of the body. In breast tissue, raloxifene blocks estrogen from attaching to its receptors, which may help prevent the growth of breast cancer cells. In bone tissue, it acts more like estrogen, helping to keep bones strong by reducing bone breakdown.

Why Raloxifene Can Matter in Cancer Care

Raloxifene is approved to lower the risk of invasive breast cancer in postmenopausal women who are at high risk of developing the disease. Since estrogen can encourage some breast cancers to grow, blocking its effects in breast tissue can help reduce cancer risk. Additionally, raloxifene helps prevent and treat osteoporosis, a condition where bones become weak and more likely to break. This bone protection is important because some breast cancer treatments and menopause itself can weaken bones.

What Patients Might See or Hear About Raloxifene

You might hear about raloxifene if your doctor talks about breast cancer prevention or osteoporosis treatment. It is usually taken as a pill once a day. You may see it mentioned in your treatment plan, medication list, pharmacy records, or in information about clinical trials. Because it can be called either raloxifene hydrochloride or Evista, it’s a good idea to ask your healthcare team if you are unsure what the name means in your care.

Where Raloxifene Might Appear in Your Care

Raloxifene may be listed in your medical records, treatment plans, or drug information sheets if your healthcare provider recommends it to reduce breast cancer risk or treat osteoporosis. It may also appear in clinical trial listings if you are participating in research studies exploring its use for other cancers.

Common Questions to Ask Your Care Team

It’s helpful to ask your doctor why raloxifene is recommended for you, how to take it, and what side effects to watch for. You might want to know how it fits with other treatments or medications you are using. If you have concerns about side effects like hot flashes, leg cramps, or blood clots, be sure to discuss these with your healthcare provider. Understanding how raloxifene compares to other options for breast cancer prevention or bone health can also be important.

Understanding the Limits and Safety of Raloxifene

This information is meant to help you understand raloxifene but does not replace medical advice. Not everyone will have the same experience, and raloxifene may not be right for everyone. Your healthcare provider can explain what is safe and appropriate for your specific situation. If you see the term in a medical report or discussion, the best step is to ask what it means for you personally.

Next Steps for Patients and Caregivers

If raloxifene is part of your care or you are considering it, talk openly with your healthcare team about your questions and concerns. They can help you understand how this medicine fits into your overall health plan and what to expect. Reliable information and clear communication can help you make informed decisions about your treatment and prevention options.

Sources

Public source information used for this glossary entry includes: